0
     

Report Added
Report already added
Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report

Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report

Summary

Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Eisai Co., Ltd. (Eisai or 'the company') is a manufacturer of pharmaceutical products. The company also involved in research and development, sale and import and export of pharmaceutical products including prescription medicines, over-the-counterover the counter (OTC) drugs and generics. Its major products include Aricept, an anti-Alzheimer's agent; Pariet/AcipHex (proton pump inhibitor); Fycompa, an anti-epileptic, Halaven, a novel anti-cancer agent; and peripheral neuropathy treatment, among others. The company manufactures products related to neurology and oncology areas. The company operates its manufacturing plants in the UK, China, India and Japan. EisaiIt primarily operates in Japan, the Americas, EMEA (Europe, the Middle East, Africa, Russia and Oceania), Asia and Latin America. The company is headquartered in Tokyo, Japan

Scope

- Detailed information on Eisai Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Eisai Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Eisai Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Eisai Co., Ltd.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Eisai Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Eisai Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Eisai Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Eisai Co., Ltd.'s business structure, strategy and prospects.

Table of Contents

Company Snapshot
Eisai Co., Ltd.: Company Overview
Eisai Co., Ltd.: Overview and Key Facts
Eisai Co., Ltd.: Overview
Eisai Co., Ltd.: Key Facts
Eisai Co., Ltd.: Key Employees
Eisai Co., Ltd.: Key Employee Biographies
Eisai Co., Ltd.: Major Products and Services
Eisai Co., Ltd.: Company History
Eisai Co., Ltd.: Management Statement
Eisai Co., Ltd.: Locations and Subsidiaries
Eisai Co., Ltd.: Key Competitors
Eisai Co., Ltd.: Company Analysis
Eisai Co., Ltd.: Business Description
Eisai Co., Ltd.: SWOT Analysis
Eisai Co., Ltd.: SWOT Overview
Eisai Co., Ltd.: Strengths
Eisai Co., Ltd.: Weaknesses
Eisai Co., Ltd.: Opportunities
Eisai Co., Ltd.: Threats
Eisai Co., Ltd.: Corporate Financial Deals Activity
Eisai Co., Ltd.: Financial Deals Overview
Eisai Co., Ltd.: Targets and Partners
Eisai Co., Ltd.: Top Deals 2019 - 2023YTD*
Eisai Co., Ltd.: Advisors
Eisai Co., Ltd.: Top Legal Advisors
Eisai Co., Ltd.: Top Financial Advisors
Eisai Co., Ltd.: Mergers and Acquisitions
Eisai Co., Ltd.: Corporate Venturing
Eisai Co., Ltd.: Partnership
Eisai Co., Ltd.: Divestments
Eisai Co., Ltd.: Recent Developments
Eisai Co., Ltd.: News and Events Summary
Eisai Co., Ltd.: Financial Deals
Eisai Co., Ltd.: Regulatory and Legal Events
Eisai Co., Ltd.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Eisai Co., Ltd.: Key Facts
Table 2: Eisai Co., Ltd.: Key Employees
Table 3: Eisai Co., Ltd.: Company History
Table 4: Eisai Co., Ltd.: Locations and Subsidiaries
Table 5: Eisai Co., Ltd.: Key Competitors
Table 6: Eisai Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Eisai Co., Ltd.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Eisai Co., Ltd.: Targets and Partners
Table 9: Eisai Co., Ltd.: Top Deals 2019 - 2023YTD*
Table 10: Eisai Co., Ltd.: Legal Advisor Ranking by Value (US$m)
Table 11: Eisai Co., Ltd.: Financial Advisor Ranking by Value (US$m)
Table 12: Eisai Co., Ltd.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 13: Eisai Co., Ltd.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 14: Eisai Co., Ltd.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 15: Eisai Co., Ltd.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 16: Eisai Co., Ltd.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 17: Eisai Co., Ltd.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 18: Eisai Co., Ltd.: News and Events Summary
Table 19: Eisai Co., Ltd.: Financial Deals
Table 20: Eisai Co., Ltd.: Regulatory and Legal Events
Table 21: Eisai Co., Ltd.: Research & Development

List of Figures
Figure 1: Eisai Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Eisai Co., Ltd.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 3: Eisai Co., Ltd.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 4: Eisai Co., Ltd.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 5: Eisai Co., Ltd.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 6: Eisai Co., Ltd.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 7: Eisai Co., Ltd.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 8: Eisai Co., Ltd.: Divestments Volume and Value Trend (2019 - YTD*2023)

Report Title: Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline